The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...
SAN FRANCISCO -- At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to ...
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...
The national health department has tried to reassure the public that the country’s HIV response is mostly funded by the ...